Stephan Dietrich A - Insider Non-Derivative Transactions at NeuBase Therapeutics, Inc. (NBSE) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Aug 2, 2023, Stephan Dietrich A's relationship to NeuBase Therapeutics, Inc. (NBSE) is Director,Officer,TenPercentOwner (Founder and CEO), and currently has 93,234 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other NBSE insiders.
Data Source: SEC.
Stephan Dietrich A - Insider Non-Derivative Transactions of NBSE Common Stock
Stephan Dietrich A - Insider Non-Derivative Transactions at NBSE
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Aug 3, 2023 | M -- (Common Stock) | 93234 | 0.02 | 93234 |
| Mar 17, 2023 | Acquisition -- (Common stock) | 153000 | 0 | 153000 |
| Feb 14, 2023 | M -- (Common Stock) | 655000 | 0 | 1471775 |